|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.Event occurred on an unknown date in 2022.Additional procode: hrs.Complainant part is not expected to be returned for manufacturer review/investigation.Without a lot number the device history records review could not be completed.Product was not returned.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
It was reported that on an unknown date in 2022, the patient noticed blisters on their foot.The patient had also been experiencing swelling and foot discoloration for the past two years.In (b)(6) 2019 the patient underwent an unknown foot fusion procedure, during which the screw in question was implanted.The patient has a known nickel allergy, and it is suspected that the blisters and swelling are related to the composition of the implanted screw.This report is for a 2.4mm cortex screw self-tapping 40mm.This is report 1 of 1 for (b)(4).
|